A Clinical Study to Assess the Effect of a Dietary Supplement on Menstrual Cycle Symptoms

About this trial

Last updated 5 months ago

Study ID

20736

Status

Completed

Type

Interventional

Phase

N/A

Placebo

Accepting

18 to 45 Years

Female

Trial Timing

Ended 10 months ago

What is this trial about?

This is a single-group, virtual clinical trial evaluating the effects of a daily dietary supplement (DITTO Cycle Supplement) on menstrual cycle symptoms across three menstrual cycles. The study investigates changes in symptom severity and quality of life through validated questionnaires including the Menstrual Symptoms Questionnaire (MSQ).

What are the participation requirements?

Inclusion Criteria

* Female-at-birth

* Aged 18-45

* In the last three menstrual cycles, has experienced three or more of the following symptoms associated with their menstrual cycle: Menstrual cramps, Bloating, Breast tenderness, Headaches, Fatigue, Muscle aches and/or joint pain, Cravings, Mood swings, Low mood, Feelings of anxiety, Irritability, Difficulty concentrating

* Generally healthy - does not live with any uncontrolled chronic disease

* Has a regular menstrual cycle length, between 23 and 35 days

* Tracks their menstrual cycle and can predict their period dates

* Anyone willing to comply with study requirements

* Anyone with no known allergies to the ingredients listed in the product

Exclusion Criteria

* Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders

* Women who are pregnant, breastfeeding, or trying to conceive

* Anyone unwilling to follow the study protocol

* Anyone in perimenopause, menopause, or experiencing menopausal-type symptoms

* Anyone with planned surgery during the study period

* Anyone with a history of substance abuse

* Anyone diagnosed with high blood pressure, high cholesterol, heart disease, heart attack, stroke, irregular heartbeat (AFib), clogged arteries, poor circulation, heart failure, or other heart conditions

* Anyone diagnosed with a hormone or reproductive health-related cancer or benign condition

* Anyone diagnosed with a menstrual health condition such as endometriosis, PCOS, or adenomyosis

* Anyone diagnosed with diabetes or other endocrine-related condition

* Anyone currently participating or planning to participate in a research study

* Anyone who has started, changed, or stopped taking hormonal birth control in the last three months

* Has a planned insertion or replacement of an IUD in the next 12 weeks